Oxidative Stress and Redox Signalling in Parkinsons Disease
Nonfiction, Health & Well Being, Medical, Specialties, Toxicology, Science & Nature, Science, Biological Sciences, Biochemistry
| Author: | Teresa Hastings, Vijayalakshmi Ravindranath, Emilio Fernandez, Jason R Cannon, J Timothy Greenamyre, Ronald Tjalkens, Pier Mastroberardino, Anumantha G Kanthasamy, Manisha Patel, Yan-Zhong Chang, Jonathan A Doorn, Richard J Smeyne, Rodrigo Franco, Jean-Christophe Rochet, Diana Anderson | ISBN: | 9781788011914 |
| Publisher: | Royal Society of Chemistry | Publication: | July 21, 2017 |
| Imprint: | Royal Society of Chemistry | Language: | English |
| Author: | Teresa Hastings, Vijayalakshmi Ravindranath, Emilio Fernandez, Jason R Cannon, J Timothy Greenamyre, Ronald Tjalkens, Pier Mastroberardino, Anumantha G Kanthasamy, Manisha Patel, Yan-Zhong Chang, Jonathan A Doorn, Richard J Smeyne, Rodrigo Franco, Jean-Christophe Rochet, Diana Anderson |
| ISBN: | 9781788011914 |
| Publisher: | Royal Society of Chemistry |
| Publication: | July 21, 2017 |
| Imprint: | Royal Society of Chemistry |
| Language: | English |
Parkinson's Disease is the second most common neurodegenerative disorder affecting millions of people worldwide. In order to find neuroprotective strategies, a clear understanding of the mechanisms involved in the dopaminergic death of cells that progresses the disease is needed. Oxidative stress can be defined as an imbalance between the production of reactive species and the ability to detoxify them and their intermediates or by-products. Oxidative damage to lipids, proteins, and DNA has been detected in autopsies from individuals with Parkinson’s Disease and so links can be made between oxidative stress and Parkinson’s Disease pathogenesis.
This book provides a thorough review of the mechanisms by which oxidative stress and redox signalling mediate Parkinson’s Disease. Opening chapters bring readers up to speed on basic knowledge regarding oxidative stress and redox signalling, Parkinson’s Disease, and neurodegeneration before the latest advances in this field are explored in detail. Topics covered in the following chapters include the role of mitochondria, dopamine metabolism, metal homeostasis, inflammation, DNA-damage and thiol-signalling. The role of genetics and gene-environment interactions are also explored before final chapters discuss the identification of potential biomarkers for diagnosis and disease progression and the future of redox/antioxidant based therapeutics.
Written by recognized experts in the field, this book will be a valuable source of information for postgraduate students and academics, clinicians, toxicologists and risk assessment groups. Importantly, it presents the current research that might later lead to redox or antioxidant – based therapeutics for Parkinson’s disease.
Parkinson's Disease is the second most common neurodegenerative disorder affecting millions of people worldwide. In order to find neuroprotective strategies, a clear understanding of the mechanisms involved in the dopaminergic death of cells that progresses the disease is needed. Oxidative stress can be defined as an imbalance between the production of reactive species and the ability to detoxify them and their intermediates or by-products. Oxidative damage to lipids, proteins, and DNA has been detected in autopsies from individuals with Parkinson’s Disease and so links can be made between oxidative stress and Parkinson’s Disease pathogenesis.
This book provides a thorough review of the mechanisms by which oxidative stress and redox signalling mediate Parkinson’s Disease. Opening chapters bring readers up to speed on basic knowledge regarding oxidative stress and redox signalling, Parkinson’s Disease, and neurodegeneration before the latest advances in this field are explored in detail. Topics covered in the following chapters include the role of mitochondria, dopamine metabolism, metal homeostasis, inflammation, DNA-damage and thiol-signalling. The role of genetics and gene-environment interactions are also explored before final chapters discuss the identification of potential biomarkers for diagnosis and disease progression and the future of redox/antioxidant based therapeutics.
Written by recognized experts in the field, this book will be a valuable source of information for postgraduate students and academics, clinicians, toxicologists and risk assessment groups. Importantly, it presents the current research that might later lead to redox or antioxidant – based therapeutics for Parkinson’s disease.
